Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Technescan Mag3 1 mg Kit ; Powder For Solution is a Health Canada–registered radiopharmaceutical drug (DIN 02329298) held by Curium Canada Inc, containing Betiatide. Health Canada lists its status as Marketed (status date 01 Oct 2019). Nexara Health has matched 16 registrations of Betiatide across 12 other regulated markets.

Health Canada registration

DIN02329298
Brand nameTechnescan Mag3
Active ingredientBetiatide
Strength1 mg
Dosage formKit ; Powder For Solution
RouteIntravenous
CompanyCurium Canada Inc
StatusMarketed — 01 Oct 2019
ClassRadiopharmaceutical
ATCV09CA03 TECHNETIUM (99m Tc) MERTIATIDE
AHFS36:68.00
Regulator recordHealth Canada DPD entry · Product monograph

Betiatide registered in other markets

16 registrations of the same molecule in 12 national registries outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Czech RepublicRenoscint Mag3—1MGRad KitRSUKL DLP
Czech RepublicTechnescan Mag3—1MGRad KitRSUKL DLP
DenmarkRenoscint MAG3Medi-Radiopharma Ltd.1 mgradiofarmaceutisk præparationssætDecentral procedureLaegemiddelstyrelsen
DenmarkTechneScan MAG3Curium Netherlands B.V.radiofarmaceutisk præparationssætNationalLaegemiddelstyrelsen
Hong KongNephromag Kit For Radiopharmaceutical Preparation 0.2mgGlobal Medical Solutions Hong Kong LimitedRegisteredDH Drug Office
IrelandIELMAG3 0.2 mg kit for radiopharmaceutical preparationROTOP Pharmaka GmbHKit for radiopharmaceutical preparationMarketedHPRA
IrelandTechneScan MAG3, powder for solution for injectionCurium Netherlands B.V.Powder for solution for injectionMarketedHPRA
MaltaRenoscint MAG3 1 mg kit for radiopharmaceutical preparationMedi-Radiopharma LtdKit For Radiopharmaceutical PreparationAuthorisedMedicines Authority
NetherlandsNephroMAG 0,2 mg, kit voor radiofarmaceutisch preparaatROTOP Pharmaka GmBHKit voor radiofarmaceutisch preparaatUitsluitend receptEU national register
NetherlandsTechnescan MAG3 1 mg kit voor radiofarmaceutisch preparaatCurium Netherlands B.V.Poeder voor oplossing voor injectieUitsluitend receptEU national register
PolandRenoscint MAG3Medi-Radiopharma Kft.1 mgZestaw do sporządzania preparatu radiofarmaceutycznegoBezterminoweURPL RPL
SingaporeTECHNESCAN MAG3 KIT 1 mg/vialQt Instruments (S) Pte Ltd1 mg/vialInjection, Powder, For SolutionPrescription OnlyHSA
South AfricaTechnescan Mag3Mallinckrodt (Pty) Ltd1 mgInjS4DoH SEP database
TaiwanIner Mertiatide Kit國家原子能科技研究院核醫製藥中心凍晶注射劑RegisteredTFDA
United KingdomBetiatide 1mg kit for radiopharmaceutical preparation—0001NHS dm+d VMP
United StatesKit for the Preparation of Technetium Tc99m MertiatideSun Pharmaceutical Industries, Inc.Injection, Powder, Lyophilized, For SolutionlistedFDA NDC

See every manufacturer of Betiatide worldwide →

Regulator price references for Betiatide

Published list or reimbursement prices for Betiatide presentations, in local currency, as at the date each registry last published. These are public reference prices, not Nexara Health quotes; strength and pack differ by row.

CountryProductStrengthPackPriceTypeSourceAs of
South AfricaTechnescan Mag31mg14,506.29 ZARsingle exit priceDoH SEP database2026-09-01

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Technescan Mag3 (DIN 02329298) marketed in Canada?

Yes. Health Canada lists DIN 02329298 as Marketed as of 01 Oct 2019.

Who holds the Canadian licence for this product?

Curium Canada Inc is the company of record in the Health Canada Drug Product Database.

Is Betiatide registered outside Canada?

Yes — Nexara Health has matched 16 registrations in 12 other markets (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02329298, status date 2019-10-01; national medicine registries: DH Drug Office, DoH SEP database, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02329298, status date 2019-10-01; national medicine registries: DH Drug Office, DoH SEP database, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database.

Health Canada Drug Product Database (DPD), DIN 02329298, status date 2019-10-01; national medicine registries: DH Drug Office, DoH SEP database, EU national register, FDA NDC, HPRA, HSA, Laegemiddelstyrelsen, Medicines Authority, NHS dm+d VMP, SUKL DLP, TFDA, URPL RPL; price sources: DoH SEP database. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.